FDA refused Summit Therapeutics' drug, and the stock's market performance was compared to Nasdaq.
1 report, 1 independent
Updated 16:30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA refused Summit Therapeutics' drug, and the stock's market performance was compared to Nasdaq.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Summit Therapeutics
biopharmaceutical company
Nothing else this week.